stoxline Quote Chart Rank Option Currency Glossary
Senseonics Holdings, Inc. (SENS)
0.3992  -0.017 (-4.04%)    04-19 16:00
Open: 0.4101
High: 0.42
Volume: 1,966,134
Pre. Close: 0.416
Low: 0.396
Market Cap: 212(M)
Technical analysis
2024-04-19 5:12:13 PM
Short term     
Mid term     
Targets 6-month :  0.6 1-year :  0.68
Resists First :  0.51 Second :  0.58
Pivot price 0.47
Supports First :  0.39 Second :  0.32
MAs MA(5) :  0.41 MA(20) :  0.49
MA(100) :  0.57 MA(250) :  0.62
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  4.3 D(3) :  3.1
RSI RSI(14): 27.2
52-week High :  1.04 Low :  0.39
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ SENS ] has closed above bottom band by 5.8%. Bollinger Bands are 25.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.42 - 0.42 0.42 - 0.42
Low: 0.39 - 0.39 0.39 - 0.39
Close: 0.39 - 0.4 0.4 - 0.4
Company Description

Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.

Headline News

Mon, 25 Mar 2024
Senseonics Board Shift: Schumm Out, Hansen In Until 2025 - - TipRanks

Wed, 06 Mar 2024
Senseonics Holdings, Inc. to Participate in the Oppenheimer 34th Annual Healthcare MedTech and Services Conference - Business Wire

Mon, 04 Mar 2024
Where Will Senseonics Holdings Inc (SENS) Stock Go Next After It Is Lower By 12.86% in a Week? - InvestorsObserver

Sat, 02 Mar 2024
Senseonics Holdings, Inc. (AMEX:SENS) Q4 2023 Earnings Call Transcript February 29, 2024 - Yahoo Finance

Fri, 01 Mar 2024
Senseonics stock slips after Q4 results (NYSE:SENS) - Seeking Alpha

Thu, 29 Feb 2024
Senseonics Holdings (SENS) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Medical - Devices
Shares Out 528 (M)
Shares Float 504 (M)
Held by Insiders 6.3 (%)
Held by Institutions 13.3 (%)
Shares Short 47,390 (K)
Shares Short P.Month 49,320 (K)
Stock Financials
EPS -0.1
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.1
Profit Margin -158.8 %
Operating Margin -312 %
Return on Assets (ttm) -28.8 %
Return on Equity (ttm) -84.8 %
Qtrly Rev. Growth 31.8 %
Gross Profit (p.s.) 0
Sales Per Share 0.03
EBITDA (p.s.) -0.15
Qtrly Earnings Growth 0 %
Operating Cash Flow -72 (M)
Levered Free Cash Flow -78 (M)
Stock Valuations
PE Ratio -4.44
PEG Ratio -0.2
Price to Book value 3.99
Price to Sales 10.58
Price to Cash Flow -2.91
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android